919 related articles for article (PubMed ID: 27110317)
1. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: An Economic Analysis.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(6):1-51. PubMed ID: 27110317
[TBL] [Abstract][Full Text] [Related]
2. Cost-Utility Analysis of Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Ontario.
Fitzgibbon KP; Plett D; Chan BCF; Hancock-Howard R; Coyte PC; Blumberger DM
Can J Psychiatry; 2020 Mar; 65(3):164-173. PubMed ID: 31801363
[TBL] [Abstract][Full Text] [Related]
3. Repetitive Transcranial Magnetic Stimulation for People With Treatment-Resistant Depression: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(4):1-232. PubMed ID: 34055112
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of electroconvulsive therapy compared to repetitive transcranial magnetic stimulation for treatment-resistant severe depression: a decision model.
Vallejo-Torres L; Castilla I; González N; Hunter R; Serrano-Pérez P; Perestelo-Pérez L
Psychol Med; 2015 May; 45(7):1459-70. PubMed ID: 25354790
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness Modeling of Repetitive Transcranial Magnetic Stimulation Compared to Electroconvulsive Therapy for Treatment-Resistant Depression in Singapore.
Zhao YJ; Tor PC; Khoo AL; Teng M; Lim BP; Mok YM
Neuromodulation; 2018 Jun; 21(4):376-382. PubMed ID: 29143405
[TBL] [Abstract][Full Text] [Related]
6. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.
Nguyen KH; Gordon LG
Value Health; 2015 Jul; 18(5):597-604. PubMed ID: 26297087
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of transcranial magnetic stimulation vs. electroconvulsive therapy for severe depression: a multi-centre randomised controlled trial.
Knapp M; Romeo R; Mogg A; Eranti S; Pluck G; Purvis R; Brown RG; Howard R; Philpot M; Rothwell J; Edwards D; McLoughlin DM
J Affect Disord; 2008 Aug; 109(3):273-85. PubMed ID: 18262655
[TBL] [Abstract][Full Text] [Related]
8. The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.
McLoughlin DM; Mogg A; Eranti S; Pluck G; Purvis R; Edwards D; Landau S; Brown R; Rabe-Heskith S; Howard R; Philpot M; Rothwell J; Romeo R; Knapp M
Health Technol Assess; 2007 Jul; 11(24):1-54. PubMed ID: 17580003
[TBL] [Abstract][Full Text] [Related]
9. Decision analysis of the cost-effectiveness of repetitive transcranial magnetic stimulation versus electroconvulsive therapy for treatment of nonpsychotic severe depression.
Kozel FA; George MS; Simpson KN
CNS Spectr; 2004 Jun; 9(6):476-82. PubMed ID: 15162090
[TBL] [Abstract][Full Text] [Related]
10. A Non-inferiority Framework for Cost-Effectiveness Analysis.
Xie X; Falk L; Brophy JM; Tu HA; Guo J; Gajic-Veljanoski O; Sikich N; Dhalla IA; Ng V
Int J Technol Assess Health Care; 2019; 35(4):291-297. PubMed ID: 31337452
[TBL] [Abstract][Full Text] [Related]
11. Cost-utility analysis of curative and maintenance repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant unipolar depression: a randomized controlled trial protocol.
Bulteau S; Laurin A; Volteau C; Dert C; Lagalice L; Schirr-Bonnans S; Bukowski N; Guitteny M; Simons L; Cabelguen C; Pichot A; Tessier F; Bonnin A; Lepage A; ; ; Vanelle JM; Sauvaget A; Riche VP
Trials; 2020 Apr; 21(1):312. PubMed ID: 32248820
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
Simpson KN; Welch MJ; Kozel FA; Demitrack MA; Nahas Z
Adv Ther; 2009 Mar; 26(3):346-68. PubMed ID: 19330495
[TBL] [Abstract][Full Text] [Related]
13. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
[TBL] [Abstract][Full Text] [Related]
14. Repetitive transcranial magnetic stimulation may be a cost-effective alternative to antidepressant therapy after two treatment failures in patients with major depressive disorder.
Zemplényi A; Józwiak-Hagymásy J; Kovács S; Erdősi D; Boncz I; Tényi T; Osváth P; Voros V
BMC Psychiatry; 2022 Jun; 22(1):437. PubMed ID: 35764989
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of resistant major depressive disorder treatment in Iranian population: a comparison between repetitive Transcranial Magnetic Stimulation with electroconvulsive.
Ghiasvand H; Moradi-Joo M; Abolhassani N; Ravaghi H; Raygani SM; Mohabbat-Bahar S
Med J Islam Repub Iran; 2016; 30():330. PubMed ID: 27390700
[TBL] [Abstract][Full Text] [Related]
16. Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients - A lifetime analysis.
Voigt J; Carpenter L; Leuchter A
PLoS One; 2017; 12(10):e0186950. PubMed ID: 29073256
[TBL] [Abstract][Full Text] [Related]
17. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(5):1-66. PubMed ID: 27099642
[TBL] [Abstract][Full Text] [Related]
18. Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: An Economic Analysis.
Babashov V; Palimaka S; Blackhouse G; O'Reilly D
Ont Health Technol Assess Ser; 2015; 15(5):1-61. PubMed ID: 26357531
[TBL] [Abstract][Full Text] [Related]
19. Cost-utility analysis of adjunct repetitive transcranial magnetic stimulation for treatment resistant bipolar depression.
Chatterton ML; Lee YY; Le LK; Nichols M; Carter R; Berk M; Mihalopoulos C
J Affect Disord; 2024 Jul; 356():639-646. PubMed ID: 38657770
[TBL] [Abstract][Full Text] [Related]
20. Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2017; 17(15):1-167. PubMed ID: 29213344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
